You searched for Antibody candidate - Page 69 of 69

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

…apart from Rytelo and Anktiva, the FDA greenlit Amgen’s T-cell engager Imdelltra for small-cell lung cancer and BeiGene’s monoclonal antibody Tevimbra for esophageal squamous cell carcinoma this year. Later this…

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 5 Jul 2022

Brii Bio takes hepatitis B treatment option

…collaboration with Vir Biotechnology, Inc. VIR-3434, also known as BRII-877, is a broadly neutralizing monoclonal antibody targeting hepatitis B virus (HBV) that is currently in phase 2 development. This is…

July 5, 2022 - 3 minutesmins - By Jim Cornall

In Depth 1 Oct 2018

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

…this vaccine could come to market within the decade, as it works by stimulating the body’s antibody response in a conventional manner and so licensing regulations should be less strict….

October 1, 2018 - 8 minutesmins - By David Cox

multiple sclerosis novartis roche ema approval

News and Trends 27 Apr 2021

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

…destroying the protective coating of nerve cells called myelin. In the case of Kesimpta, the antibody drug is designed to destroy harmful B cells as does Roche’s Ocrevus, except Kesimpta…

April 27, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 4 Aug 2022

Gilead Sciences set to acquire MiroBio for $405M

…cash, subject to customary adjustments. The acquisition will provide Gilead with MiroBio’s discovery platform and entire portfolio of immune inhibitory receptor agonists. MiroBio’s lead investigational antibody, MB272, is a selective…

August 4, 2022 - 2 minutesmins - By Jim Cornall

paris ermium therapeutics autoimmune disease

Startup Scout 18 Oct 2019

This Biotech Fights Autoimmune Disease with Rare Immune Cells

…specific than existing drugs. The UK biotech MiroBio was founded earlier this month to develop antibody treatments that block immune cells called T-cells from attacking healthy tissue. The Dutch company…

October 18, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 28 Oct 2016

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

…collaboration to evaluate its lead candidate NY-ESO SPEAR T-cell therapy in combination with MSD’s Keytruda (pembrolizumab). Adaptimmune will sponsor the trial aimed at multiple myeloma, a form of blood cancer…

October 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

The 2024 drug approval list: Eight new treatments you should know about

Brii Bio takes hepatitis B treatment option

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

Gilead Sciences set to acquire MiroBio for $405M

This Biotech Fights Autoimmune Disease with Rare Immune Cells

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!